.Kailera Therapies has launched into the progressively jampacked being overweight room along with a ...
.With very early period 1 data right now out in the wild, metabolic disease ensemble Metsera is actu...
.Rivus Pharmaceuticals has revealed the information behind its stage 2 obesity succeed in heart fail...
.Bristol Myers Squibb is spending Top Medicine $110 million upfront to develop reagents for ex-spous...
.Novartis has actually inked a bargain possibly worth much more than $1 billion with Flagship-founde...
.Lately debuted Metsera is actually unfolding some period 1 record for its own GLP-1 receptor agonis...
.Among the hereditary medications branches nationality, Front runner Pioneering is actually revealin...
.BioAge Labs is actually eyeing all around $180 million in preliminary earnings from an IPO and an e...
.An attempt by Merck & Co. to unlock the microsatellite dependable (MSS) metastatic intestines ca...
.Spain-based Asabys Partners has shut a fund of 180 million euros ($ 200 million), cash that will ap...